SCHEMBL18700477

SCHEMBL18700477

Nc1ccc(Cl)cc1-c1cc(O)ncn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 5/20 0.47
DYRK3 O43781 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CDK5 Q00535 1/20 0.41
DYRK1A Q13627 1/20 0.41
CDK5R1 Q15078 1/20 0.41
DYRK2 Q92630 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
ALOX15 P16050 2/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TSHR P16473 3/20 0.39
CYP3A4 P08684 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
KMO O15229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL39774 0.83 IDO1 (0.50) IDO1DYRK3CCNA2CDK2CDK5
SCHEMBL16971796 0.81 KMO (0.50) IDO1CYP3A4KMO
SCHEMBL16971666 0.80 KMO (0.39) IDO1SMN1; SMN2ALDH1A1ALOX15HPGD
SCHEMBL30271837 0.80 KMO (0.39) IDO1SMN1; SMN2ALDH1A1HPGDKMO
SCHEMBL16971315 0.80 KMO (0.39) IDO1SMN1; SMN2ALDH1A1HPGDKMO
SCHEMBL22211534 0.77 IDO1 (0.42) IDO1DYRK3CCNA2CDK2CDK5
SCHEMBL17662013 0.76 JAK2 (0.44) IDO1KMOJAK2JAK1
SCHEMBL16971331 0.76 IDO1 (0.44) IDO1DYRK3CCNA2CDK2CDK5
SCHEMBL16974619 0.76 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10TDP1KMO
SCHEMBL16068268 0.76 CA2 (0.46) IDO1DYRK3CCNA2CDK2CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170096429-A1 MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2017-04-06 US disclosed
US-20170096429-A1 MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2017-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170096429-A1 MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS TFPI, TFPI2, F2 IDO1 2213/4885DYRK3 254/4885CCNA2 1420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.